Package Leaflet: Information for the User
Dimethyl Fumarate Sandoz Pharmaceutical 120 mg hard gastro-resistant capsules EFG
Dimethyl Fumarate Sandoz Pharmaceutical 240 mg hard gastro-resistant capsules EFG
dimethyl fumarate
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
What Dimethyl Fumarate Sandoz Pharmaceutical is
Dimethyl Fumarate Sandoz Pharmaceutical is a medicine that contains dimethyl fumarateas the active substance.
What Dimethyl Fumarate Sandoz Pharmaceutical is used for
Dimethyl fumarate is used to treat multiple sclerosis (MS) in patients from 13 years of age.
MS is a long-term disease that affects the central nervous system (CNS), which includes the brain and spinal cord. MS is characterized by repeated attacks (relapses) of neurological symptoms. The symptoms vary from person to person but often include: difficulty walking, balance problems, and vision problems (e.g., blurred or double vision). These symptoms can disappear completely when the relapse is over, but some problems may remain.
How Dimethyl Fumarate Sandoz Pharmaceutical works
This medicine seems to work by preventing the body's defense system from damaging the brain and spinal cord. This may also help to delay future disability from MS.
Do not take Dimethyl Fumarate Sandoz Pharmaceutical
Warnings and precautions
Dimethyl fumarate may affect your white blood cell count, kidneys, and liver. Before you start taking dimethyl fumarate, your doctor will do a blood test to check your white blood cell count and to make sure your kidneys and liver are working properly. Your doctor will do regular blood tests during treatment. If you have a low white blood cell count during treatment, your doctor may consider additional tests or stop your treatment.
Tell your doctorbefore you start taking dimethyl fumarate if you have:
Herpes zoster (shingles) may occur during treatment with dimethyl fumarate. In some cases, serious complications have occurred. You must tell your doctor immediatelyif you suspect you have any symptoms of shingles.
If you think your MS is getting worse (e.g., weakness or changes in vision) or you notice any new symptoms, talk to your doctor directly, as they could be symptoms of a rare brain infection called PML. PML is a serious disease that can cause death or severe disability.
A rare but serious kidney disorder (called Fanconi syndrome) has been reported with a medicine that contains dimethyl fumarate in combination with other fumaric acid esters, which is used to treat psoriasis (a skin disease). If you notice that you are urinating more, are thirstier and drink more than usual, your muscles seem weaker, you break a bone or simply have aches and pains, tell your doctor as soon as possible so that this can be investigated further.
Children and adolescents
Do not give this medicine to children under 10 years of age as there is no data available for this age group.
Other medicines and Dimethyl Fumarate Sandoz Pharmaceutical
Tell your doctor or pharmacistif you are taking, have recently taken or might take any other medicines, in particular:
Taking Dimethyl Fumarate Sandoz Pharmaceutical with alcohol
After taking dimethyl fumarate, you should avoid consuming more than a small amount (more than 50 ml) of strong alcoholic beverages (with an alcohol content of more than 30%, such as spirits) for the first hour because alcohol may interact with this medicine. This may cause stomach inflammation (gastritis), especially in people who are prone to this condition.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Pregnancy
Information on the effects of this medicine in the fetus if used during pregnancy is limited. Do not use this medicine during pregnancy unless you have discussed it with your doctor and this medicine is strictly necessary.
Breastfeeding
It is not known if dimethyl fumarate passes into breast milk. Your doctor will inform you if you should stop breastfeeding, or if you should stop taking dimethyl fumarate. This decision involves weighing the benefits of breastfeeding for your child and the benefits of treatment for you.
Driving and using machines
Dimethyl fumarate is not expected to affect your ability to drive and use machines.
Dimethyl Fumarate Sandoz Pharmaceutical contains sodium
This medicine contains less than 1 mmol of sodium (23 mg) per capsule; this is essentially “sodium-free”.
Follow the instructions for administration of this medicine exactly as told by your doctor. If you are unsure, ask your doctor again.
Starting dose
120 mg twice a day.
Take this starting dose for the first 7 days, then take the usual dose.
Usual dose
240 mg twice a day.
Dimethyl Fumarate Sandoz Pharmaceutical is taken by mouth.
The capsules should be swallowed whole, with some water. Do not break, crush, dissolve, or chew the capsules because this may increase some side effects.
Take Dimethyl Fumarate Sandoz Pharmaceutical with food, this helps to reduce some of the very common side effects (listed in section 4).
If you take more Dimethyl Fumarate Sandoz Pharmaceutical than you should
If you take too many capsules, tell your doctor immediately. You may experience side effects similar to those described below in section 4.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone 91 562 04 20, indicating the medicine and the amount ingested.
If you forget to take Dimethyl Fumarate Sandoz Pharmaceutical
Do not take a double doseto make up for forgotten doses.
You can take the forgotten dose if it is at least 4 hours between doses. Otherwise, wait until the next dose.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Serious side effects
Dimethyl fumarate may lower your lymphocyte count(a type of white blood cell). A low lymphocyte count can increase the risk of infection, including a rare brain infection called progressive multifocal leukoencephalopathy (PML). PML can cause death or severe disability. PML has occurred after 1 to 5 years of treatment, so your doctor will continue to monitor your lymphocytes during treatment, and you should be aware of any possible symptoms of PML, as described below. The risk of PML may be higher if you have previously taken a medicine that has weakened your immune system.
The symptoms of PML can be similar to those of an MS relapse. The symptoms may include new or worsening weakness on one side of the body; clumsiness; changes in vision, thinking, or memory; or confusion or changes in personality, or difficulty speaking and communicating that may persist for more than several days. Therefore, it is very important that you talk to your doctor as soon as possible if you think your MS is getting worse or if you notice any new symptoms while being treated with dimethyl fumarate. Also, inform your partner or caregivers about your treatment. It is possible that symptoms may arise that you are not aware of on your own.
Call your doctor immediately if you have any of these symptoms
Severe allergic reactions
The frequency of severe allergic reactions cannot be estimated from the available data (frequency not known).
Facial or body redness (flushing) is a very common side effect. However, if the redness is accompanied by a rash or hivesandyou have any of the following symptoms:
this could be a severe allergic reaction (anaphylaxis).
Stop taking Dimethyl Fumarate Sandoz Pharmaceutical and call your doctor immediately.
Other side effects
Very common(may affect more than 1 in 10 people)
Taking the medicine with foodmay help reduce the above side effects.
While being treated with dimethyl fumarate, it is common for urine tests to show the presence of ketones, substances that are naturally produced by the body.
Tell your doctorabout these side effects. Your doctor may reduce your dose. Do not reduce the dose unless your doctor tells you to.
Common(may affect up to 1 in 10 people)
Side effects that may appear in blood or urine tests
Uncommon(may affect up to 1 in 100 people)
Not known(cannot be estimated from the available data)
Children (13 years of age and older) and adolescents
The side effects described above also apply to children and adolescents.
Some side effects were reported more frequently in children and adolescents than in adults,
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly to the Spanish Medicines Vigilance System for Human Use: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the blister and carton after EXP. The expiry date is the last day of the month stated.
Do not store above 30°C.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
Composition of Dimethyl Fumarate Sandoz Pharmaceutical
Dimethyl Fumarate Sandoz Pharmaceutical 120 mg: each hard gastroresistant capsule contains 120 mg of dimethyl fumarate.
Dimethyl Fumarate Sandoz Pharmaceutical 240 mg: each hard gastroresistant capsule contains 240 mg of dimethyl fumarate.
Appearance of the product and container contents
Hard gastroresistant capsules
Dimethyl Fumarate Sandoz Pharmaceutical 120 mg are hard capsules with a white body and a light green cap with the imprint '120 mg' on the capsule body. Approximate size 19 mm long and 9 mm wide.
Dimethyl Fumarate Sandoz Pharmaceutical 240 mg are hard capsules of light green color with the imprint '240 mg' on the capsule body. Approximate size 23 mm long and 9 mm wide.
Dimethyl Fumarate Sandoz Pharmaceutical is presented in Al/PVC/PVDC blister packs or calendarized blisters or single-dose precut blisters.
Dimethyl Fumarate Sandoz Pharmaceutical 120 mg hard gastroresistant capsules EFG:
Container sizes: blisters with 14 or 28 hard gastroresistant capsules.
Calendarized blisters with 14 or 28 hard gastroresistant capsules.
Single-dose precut blisters with 14x1 hard gastroresistant capsules.
Dimethyl Fumarate Sandoz Pharmaceutical 240 mg hard gastroresistant capsules EFG:
Container sizes: blisters with 28, 56, 168 or 196 hard gastroresistant capsules.
Calendarized blisters with 28, 56, 168 or 196 hard gastroresistant capsules.
Single-dose precut blisters with 56x1 and 168x1 hard gastroresistant capsules.
Only some container sizes may be marketed.
Marketing authorization holder and manufacturer
Marketing authorization holder
Sandoz Pharmaceutical, S.A.
Centro Empresarial Parque Norte
Edificio Roble
C/ Serrano Galvache, 56
28033 Madrid
Spain
Manufacturer
LEK Pharmaceuticals d.d.
Verovškova ulica, 57
SLO-1526 Ljubljana
Slovenia
or
Zaklady Farmaceutyczne Polpharma S.A. ul. Metalowca 2 39-460 Nowa Deba Poland |
This medicinal product is authorized in the Member States of the European Union under the following names:
Austria | Dimethylfumarat 1A Pharma 120 mg - magensaftresistente Hartkapseln; Dimethylfumarat 1A Pharma 240 mg - magensaftresistente Hartkapseln |
Denmark | Dimethyl fumarate 1A Farma |
Finland | Dimethyl fumarate 1A Farma 120 mg enterokapseli, kova Dimethyl fumarate 1A Farma 240 mg enterokapseli, kova |
Germany | Dimethylfumarat HEXAL 120 mg magensaftresistente Hartkapseln; Dimethylfumarat HEXAL 240 mg magensaftresistente Hartkapseln |
Hungary | Dimetil-fumarát Hexal 120 mg gyomornedvellenálló kemény kapszula Dimetil-fumarát Hexal 240 mg gyomornedvellenálló kemény kapszula |
Iceland | Dimethyl fumarate 1A Farma |
Ireland | Dimethyl fumarate Rowex 120 mg hard gastroresistant capsules Dimethyl fumarate Rowex 240 mg hard gastroresistant capsules |
Netherlands | Dimethylfumaraat Sandoz 120 mg, harde maagsapresistente capsules; Dimethylfumaraat Sandoz 240 mg, harde maagsapresistente capsules |
Norway | Dimethyl fumarate 1A Farma |
Portugal Spain | Fumarato de dimetilo Sandoz 120 mg cápsulas gastrorresistentes; Fumarato de dimetilo Sandoz 240 mg cápsulas gastrorresistentes Fumarato de dimetilo Sandoz Farmacéutica 120 mg cápsulas gastrorresistentes EFG Fumarato de dimetilo Sandoz Farmacéutica 240 mg cápsulas gastrorresistentes EFG |
Sweden | Dimethyl fumarate 1A Farma |
Date of the last revision of this prospectus:June 2024.
Detailed information on this medicinal product is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es.